Anti-Counterfeiting Program in Ghana Now Using Advanced Handheld Detection Technology

Thermo Scientific TruScan Instruments Used to Detect Fake Anti-Malarial Drugs

The Thermo Scientific TruScan GP analyzer quickly and accurately detects counterfeit drugs. (Photo: Business Wire)

TEWKSBURY, Mass.--()--Ghana-based Center for Pharmaceutical Advancement and Training (CePAT), part of the U.S. Pharmacopeial Convention’s (USP) Global Health Impact Program, is now using handheld anti-counterfeiting technology in its fight to detect fake anti-malaria drugs, a major problem in Ghana and Sub-Saharan Africa.

Thermo Scientific TruScan instruments are ideal for the CePAT effort because of their streamlined user interface, ease of implementation and inherent specificity, designed to allow key personnel at the point of need to quickly and accurately detect counterfeit drugs.

“Malaria is a major health issue in this region and anti-malarial drugs are critical to survival,” said Dr. Patrick Lukulay, vice president at USP in charge of the Promoting Quality of Medicines program. “Sadly, counterfeiters are exploiting this need and attempting to capitalize, and we need ways to stay ahead of them. Because TruScan is easy to learn and delivers immediate results, we’re able to make it an integral part of our ongoing effort to safeguard the public and improve human health.”

“We’re pleased to play a role in a very important public health issue,” said Bob Brush, business development manager at Thermo Fisher Scientific. “The work CePAT is doing is precisely what we designed TruScan to do, make it easy to confirm that a substance – whether it’s a pill, powder or liquid and even if it’s already packaged and shipped – is what it says it is.”

Thermo Fisher Scientific designed the TruScan platform for rapid, accurate material identification through the use of highly selective Raman technology. More information on the Thermo Scientific TruScan instruments can be found by visiting www.thermoscientific.com/rmid.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our four premier brands – Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Thermo Fisher Scientific
Tewksbury, MA
Cindy Bocko, +1-978-215-1392
cindy.bocko@thermofisher.com
or
Secondary Contact Information:
Greenough
Boston, Mass., USA
Gaby Berkman, +1-617-275-6553
gberkman@greenoughcom.com

Release Summary

Ghana-based Center for Pharmaceutical Advancement and Training (CePAT), part of the U.S. Pharmacopeial Convention (USP), is now using the Thermo Scientific TruScan GP to detect fake drugs.

Contacts

Media Contact Information:
Thermo Fisher Scientific
Tewksbury, MA
Cindy Bocko, +1-978-215-1392
cindy.bocko@thermofisher.com
or
Secondary Contact Information:
Greenough
Boston, Mass., USA
Gaby Berkman, +1-617-275-6553
gberkman@greenoughcom.com